Last Posted: May 31, 2018
- Concurrent risk-reduction surgery in patients with increased lifetime risk for breast and ovarian cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database.
Elmi Maryam et al. Breast cancer research and treatment 2018 May - PARP Inhibitor Shows Promise in Patients With BRCA-Mutated Pancreatic Cancer
ASCO Post, May 23, 2018 - The genomic medicine model: an integrated approach to implementation of family health history in primary care.
Orlando Lori A et al. Personalized medicine 2013 May 10(3) 295-306 - Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population.
Goidescu Iulian Gabriel et al. Clujul medical (1957) 2018 91(2) 157-165 - Previvor: An Oncology Nurse's Story of Cancer Risk Reduction Through Genetic Testing.
Kelly Joanne et al. Clinical journal of oncology nursing 2018 Jun 22(3) 247-248 - Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer.
Barcenas Carlos H et al. Journal of the National Comprehensive Cancer Network : JNCCN 2018 May 16(5) 518-524 - Patients' Views of Treatment-Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing.
Wright Sarah et al. Journal of genetic counseling 2018 May - The 'Jolie Effect' Was A Game-Changer For Breast Cancer, But It Was Just A Start
E Stallings, Huffington Post, May 14, 2018 - Validation of Version 3.0 of the Breast Cancer Genetics Referral Screening Tool (B-RST™).
Bellcross Cecelia et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 May - Precision Medicine in Action: How well does cascade screening for hereditary conditions work in the real world?
WD Dotson et al, CDC Blog Post, May 8, 2018
.png)
No hay comentarios:
Publicar un comentario